This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
TiGenix NV
TiGenix NV, a pioneering biotechnology company headquartered in Belgium, focuses on developing innovative cell-based therapies for severe medical conditions. Founded in 2007, TiGenix has made significant strides in the regenerative medicine sector, particularly in the treatment of inflammatory and degenerative diseases. The company is renowned for its flagship product, ChondroCelect, which is the first cell-based therapy approved in Europe for the repair of cartilage defects in the knee. TiGenix's commitment to advancing cell therapy positions it as a leader in the industry, with a strong emphasis on research and development. With a robust pipeline and strategic partnerships, TiGenix continues to enhance its market presence, aiming to transform patient care through cutting-edge therapeutic solutions.
DitchCarbon Score
How does TiGenix NV's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TiGenix NV's score of 75 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
TiGenix NV, headquartered in Belgium (BE), currently does not report specific carbon emissions data, as no emissions figures are available. However, the company is a current subsidiary of Takeda Pharmaceutical Company Limited, which influences its climate commitments and initiatives. TiGenix NV's climate strategy is aligned with the broader sustainability goals set by Takeda. This includes initiatives under the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded from Takeda. While specific reduction targets for TiGenix NV are not detailed, the overarching commitments from Takeda aim to significantly reduce emissions across all scopes, including Scope 1, 2, and 3. As part of its commitment to sustainability, TiGenix NV is expected to adhere to the climate pledges and initiatives established by its parent company, Takeda, which focuses on reducing its environmental impact and enhancing climate resilience. The absence of specific emissions data highlights the need for ongoing transparency and accountability in reporting climate performance.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 96,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 161,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 3 | 226,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
TiGenix NV is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
